L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine

Details L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine

1991-06-19

1992-12-15

Cintins, Marianne M.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

562554, C07C 53128

Patent

active

051718855

ABSTRACT:
The pure isomers L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine are provided. The L-S-isomer has utility, for example, in causing the depletion of glutathione, a major protectant molecule in tumors and certain parasites. The L-R-isomer has utility as a compound decreasing further uptake and thus effect of the L-S-isomer and for causing glutathione depletion specific to the kidney. The isolation of pure isomers from L-buthionine-SR-sulfoximine enables treatment at lower dosages without cross effects.
The pure L-buthionine-S-sulfoximine isomer is obtained from L-buthionine-SR-sulfoximine by recrystallization preferably by forming a solution of L-buthionine-SR-sulfoximine in water at a concentration of 0.8M and cooling to form crystals enriched in the L-R-isomer and a filtrate enriched in L-S-isomer, drying the filtrate to obtain a solid, dissolving the solid in ethanol, adding trifluoroacetic acid to form acid salt and provide solvent, then adding hexane to cause crystal formation, then converting the crystals to the free zwitterion using ion exchange resin.
Both isomers can be separated concurrently by reverse phase chromatography in Cu.sup.++ /D-proline buffers.

REFERENCES:
Bump, E. A., et al, Int. J. Radiation Oncology Biol., Phys., vol. 8, 439-442 (1982).
Ozols, R. F., et al, Biochemical Pharmacology, vol. 36, No. 1, 147-153 (1987).
Kramer, R. A., et al, Int. J. Radiation Oncology Biol. Phys., vol. 16, 1325-1329 (May 1989).
McNally, N. J., et al, Int. J. Radiation Oncology Biol. Phys., vol. 16, 1331-1334 (May 1989).
Arrick, B. A., et al, J. Exp. Med, vol. 153, 720-725 (Mar. 1981).
Brodie, A. E., et al, Toxicology and Applied Pharmacology, 77, 381-387, 1985.
Anderson, M. E., et al, Proc. Natl. Acad. Sci. USA, vol. 80, pp. 707-711, Feb. 1983.
Richman, Paul G., et al, The Journal of Biological Chemistry, 248, No. 19, 6684-6690, 1973.
Griffith, O. W., Anal. Biochem. 106, 207-212 (1980).
Glutathione Centennial Molecular Perspectives and Clinical Implications (Taniguchi, N., et al, eds.), 1989, Academic Press, pp. 285-299. (Chapter titled "L-Buthionine-SR-Sulfoximine: Mechanism of Action, Resolution of Diastereomers and Use as a Chemotherapeutic Agent," by Owen W. Griffith.
Christensen, B. W., et al, Chemical Communications, pp. 169-170 (1969).
Griffith, W. W., The Journal of Biological Chemistry, vol. 257, No. 22, pp. 13704-13712 (1982).

Affiliated with

Also associated with

Rating

L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-buthionine-S-sulfoximine and L-buthionine-R-sulfoximine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2094428